197 related articles for article (PubMed ID: 16479096)
1. Antiplatelet therapy in stroke prevention: present and future.
Caplan LR
Cerebrovasc Dis; 2006; 21 Suppl 1():1-6. PubMed ID: 16479096
[TBL] [Abstract][Full Text] [Related]
2. Newer antiplatelet therapies in stroke prevention.
Davis SM; Donnan GA
Aust Fam Physician; 2001 Feb; 30(2):129-34. PubMed ID: 11280112
[TBL] [Abstract][Full Text] [Related]
3. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
[No Abstract] [Full Text] [Related]
4. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?
Aw D; Sharma JC
Postgrad Med J; 2012 Jan; 88(1035):34-7. PubMed ID: 22121248
[TBL] [Abstract][Full Text] [Related]
6. [Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?].
Diener C
MMW Fortschr Med; 2008 May; 150(21):7. PubMed ID: 18578065
[No Abstract] [Full Text] [Related]
7. [ASS plus dipyridamole or clopidogrel after stroke: what is the best secondary prevention?].
Einecke D
MMW Fortschr Med; 2008 May; 150(21):6-7. PubMed ID: 18575244
[No Abstract] [Full Text] [Related]
8. Antiplatelet therapy to prevent recurrent stroke: Three good options.
Mansoor AH; Mujtaba MT; Silver B
Cleve Clin J Med; 2013 Dec; 80(12):787-95. PubMed ID: 24307163
[TBL] [Abstract][Full Text] [Related]
9. New modalities and aspects of antiplatelet therapy for stroke prevention.
Uchiyama S; Nakamura T; Yamazaki M; Kimura Y; Iwata M
Cerebrovasc Dis; 2006; 21 Suppl 1():7-16. PubMed ID: 16479097
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet agents and randomized trials.
Diener HC
Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
[TBL] [Abstract][Full Text] [Related]
11. Medications used to prevent adhesion and clotting.
Lassiter TF
Lippincotts Prim Care Pract; 2000; 4(6):619-32; quiz 633-5. PubMed ID: 11933375
[No Abstract] [Full Text] [Related]
12. Aspirin and antiplatelet agent resistance: implications for prevention of secondary stroke.
Greer DM
CNS Drugs; 2010 Dec; 24(12):1027-40. PubMed ID: 20932071
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet therapy in stroke prevention.
Apostolakis S; Marín F; Lip GY
Adv Cardiol; 2012; 47():141-54. PubMed ID: 22906909
[TBL] [Abstract][Full Text] [Related]
14. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
Simmons BB; Yeo A; Fung K; ;
Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet agents. European perspective.
Sivenius J; Kaste M
Adv Neurol; 2003; 92():293-9; discussion 301-5. PubMed ID: 12760196
[No Abstract] [Full Text] [Related]
16. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
Gebel JM
J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic drugs for the secondary prevention of ischemic stroke.
Nenci GG; Goracci S
Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelets and stroke outcomes: state of the science.
Meyer D
Crit Care Nurs Clin North Am; 2009 Dec; 21(4):517-28. PubMed ID: 19951767
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy: a neurology perspective.
Brass LM
Manag Care; 2000 Oct; 9(10 Suppl):13-5. PubMed ID: 11729420
[No Abstract] [Full Text] [Related]
20. Antiplatelet therapy: a neurology perspective.
Brass LM
Manag Care; 2000 May; 9(5 Suppl):15-7. PubMed ID: 11729408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
